Skip to main content
. 2000 Dec 9;321(7274):1445. doi: 10.1136/bmj.321.7274.1445

Table 4.

Adverse events for which the difference between the galantamine and placebo groups was at least 5%. Values are numbers (percentages) of patients

Adverse event Placebo group (n=215) Galantamine 24 mg (n=220) Galantamine 32 mg (n=218)
Nausea 26 (12) 82 (37) 87 (40)
Vomiting 9 (4) 45 (20) 37 (17)
Diarrhoea 16 (7) 16 (7) 29 (13)
Dizziness 10 (5) 24 (11) 26 (12)
Headache 7 (3) 21 (10) 25 (11)
Anorexia 0 22 (10) 23 (11)
Weight loss  1 (0.5) 17 (8) 11 (5)
Any adverse event 165 (77) 182 (83) 194 (89)